Risk factors for late renal allograft dysfunction: effects of baseline glomerular size

Mingxi Li1, Kathy M Nicholls, Gavin J Becker

  • 1Department of Nephrology, Peking Union Medical College Hospital, Beijing, China.

Journal of Nephrology
|December 24, 2002
PubMed

Insights

Glomerular size in baseline kidney biopsies predicts long-term allograft function. Larger glomerular size, indicating hypertrophy, is a risk factor for chronic renal allograft dysfunction.

Area of Science:

  • Nephrology
  • Transplantation Immunology
  • Pathology

Background:

  • Alloantigen-dependent and independent factors influence late allograft dysfunction.
  • Donor kidney mass is an understudied factor in allograft outcomes.
  • Glomerular hypertrophy is hypothesized to be a risk factor for graft function decline.

Purpose of the Study:

  • To investigate the role of glomerular size in predicting late allograft dysfunction.
  • To determine if glomerular hypertrophy is a risk factor for chronic renal allograft dysfunction.

Main Methods:

  • Morphometric analysis of baseline graft biopsies (1990-1998) using maximal profile area (MPA) for glomerular size.
  • Correlation analysis between glomerular size and creatinine clearance (Ccr) at multiple time points post-transplant.
  • Multivariate analysis to identify covariates associated with Ccr, including glomerular size, global glomerulosclerosis (GS%), baseline Ccr, cold ischemic time (CIT), and rejection episodes.

Main Results:

  • Eighty-six patients were analyzed.
  • Maximal profile area (MPA) was significantly correlated with Ccr at 6 months, 1, 3, and 4 years post-transplant.
  • Other significant covariates included GS%, baseline Ccr, CIT, and rejection episodes.

Conclusions:

  • Glomerular size in baseline biopsies is a significant predictor of late allograft function.
  • Hypertrophied glomeruli, along with other factors, contribute to chronic renal allograft dysfunction.
Abstract

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...